Literature DB >> 16519005

GDNF and addiction.

Dorit Ron1, Patricia H Janak.   

Abstract

Biochemical adaptations to drugs of abuse and alcohol are especially profound in midbrain dopaminergic neurons. Long-lasting molecular and structural changes in mesolimbic dopaminergic neurons that result from chronic exposure to drugs of abuse and alcohol are thought to underlie adverse behaviors such as compulsive drug seeking and relapse. Recent studies suggest that a subset of these changes is prevented/reversed by activation of the glial cell line-derived neurotrophic factor (GDNF) signaling pathway. Behavioral effects of drugs of abuse such as cocaine and alcohol are also negatively regulated by GDNF: inhibition of the endogenous GDNF pathway enhances the activity of drugs of abuse, while administration of GDNF reduces the severity of the effects. In this review, we summarize the data implicating GDNF as a negative regulator of drug and alcohol addiction. We also provide evidence to suggest that therapies that activate GDNF signaling may be useful for the treatment of drug and alcohol addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16519005     DOI: 10.1515/revneuro.2005.16.4.277

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  18 in total

1.  Neonatal fibroblast growth factor treatment enhances cocaine sensitization.

Authors:  Sarah M Clinton; Cortney A Turner; Shelly B Flagel; Danielle N Simpson; Stanley J Watson; Huda Akil
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

Review 2.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

Review 3.  Neurobiology of the incubation of drug craving.

Authors:  Charles L Pickens; Mikko Airavaara; Florence Theberge; Sanya Fanous; Bruce T Hope; Yavin Shaham
Journal:  Trends Neurosci       Date:  2011-07-20       Impact factor: 13.837

Review 4.  Targeted delivery of nano-therapeutics for major disorders of the central nervous system.

Authors:  Huile Gao; Zhiqing Pang; Xinguo Jiang
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

5.  Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor.

Authors:  Sebastien Carnicella; Ryoji Amamoto; Dorit Ron
Journal:  Alcohol       Date:  2009-02       Impact factor: 2.405

Review 6.  Update of neurotrophic factors in neurobiology of addiction and future directions.

Authors:  Maryna Koskela; Susanne Bäck; Vootele Võikar; Christopher T Richie; Andrii Domanskyi; Brandon K Harvey; Mikko Airavaara
Journal:  Neurobiol Dis       Date:  2016-05-14       Impact factor: 5.996

Review 7.  A dual-hit animal model for age-related parkinsonism.

Authors:  Heather A Boger; Ann-Charlotte Granholm; Jacqueline F McGinty; Lawrence D Middaugh
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

8.  GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.

Authors:  Sebastien Carnicella; Viktor Kharazia; Jerome Jeanblanc; Patricia H Janak; Dorit Ron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-09       Impact factor: 11.205

9.  Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving.

Authors:  Lin Lu; Xi Wang; Ping Wu; Chunmei Xu; Mei Zhao; Marisela Morales; Brandon K Harvey; Barry J Hoffer; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2009-04-05       Impact factor: 13.382

10.  Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.

Authors:  William M Pardridge; Ruben J Boado
Journal:  Pharm Res       Date:  2009-07-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.